HeimAXGN • NASDAQ
add
AxoGen, Inc Common Stock
Við síðustu lokun
13,61 $
Dagbil
13,71 $ - 13,84 $
Árabil
5,56 $ - 15,76 $
Markaðsvirði
595,27 m. USD
Meðalmagn
400,86 þ.
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
NASDAQ
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (USD) | sep. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 48,64 m. | 17,86% |
Rekstrarkostnaður | 36,75 m. | 2,87% |
Nettótekjur | -1,86 m. | 54,56% |
Hagnaðarhlutfall | -3,82 | 61,45% |
Hagnaður á hvern hlut | 0,07 | 600,00% |
EBITDA | 1,40 m. | 150,05% |
Virkt skatthlutfall | — | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (USD) | sep. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 24,53 m. | -24,73% |
Heildareignir | 191,98 m. | -1,36% |
Heildarskuldir | 92,58 m. | -4,38% |
Eigið fé alls | 99,41 m. | — |
Útistandandi hlutabréf | 44,01 m. | — |
Eiginfjárgengi | 6,02 | — |
Arðsemi eigna | -0,41% | — |
Ávöxtun eigin fjár | -0,47% | — |
Peningaflæði
Breyting á handbæru fé
| (USD) | sep. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | -1,86 m. | 54,56% |
Handbært fé frá rekstri | 3,90 m. | 139,91% |
Reiðufé frá fjárfestingum | -5,00 m. | -183,42% |
Reiðufé frá fjármögnun | 572,00 þ. | 11.340,00% |
Breyting á handbæru fé | -527,00 þ. | -106,91% |
Frjálst peningaflæði | 3,60 m. | 424,35% |
Um
Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering. Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is part of the Sid Martin Biotechnology Incubator.
As of 2019, Axogen was the only commercially available allograft approved by the Food and Drug Administration for clinical use. Wikipedia
Stofnsett
2002
Höfuðstöðvar
Vefsvæði
Starfsfólk
427
